PellePharm, Inc. — Form D
PellePharm, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-03. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-07-03
- Form: D
- Accession: 0001611568-18-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.5M
- Investors: 7
- Date of first sale: 2018-06-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315962
Issuer
- Name: PellePharm, Inc.
- CIK: 0001611568
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 101 MISSION STREET, SUITE 2050, SAN FRANCISCO, CA, 94105
- Phone: (510) 502-6144
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Ervin Epstein, M.D. | Director | San Francisco, CA |
| Neil Kumar, Ph.D. | Director | San Francisco, CA |
| Frank McCormick, Ph.D. | Director | San Francisco, CA |
| Sanuj Ravinddran, M.D. | Director | San Francisco, CA |
| Jean Y Tang, M.D., Ph.D. | Director | San Francisco, CA |
| Sanuj Ravinddran, M.D. | Executive Officer | San Francisco, CA |
| Sanuj Ravinddran, M.D. | Promoter | San Francisco, CA |
| Mark de Souza | Director | Hingham, MA |
| Mark de Souza | Executive Officer | Hingham, MA |
| Frank McCormick | Director | PALO ALTO, CA |
| Neil Kumar | Director | PALO ALTO, CA |
| Ervin Epstein, M.D. | Executive Officer | San Francisco, CA |
| Mark De Souza, Ph.D. | Director | Berkeley, CA |
| Mark De Souza, Ph.D. | Executive Officer | Berkeley, CA |
| Jean Tang, M.D., Ph.D. | Director | Stanford, CA |
| Ervin Epstein | Director | Orinda, CA |
| Ervin Epstein | Executive Officer | Orinda, CA |
| Jean Tang | Director | Stanford, CA |
| Katrin Andreasson | Director | Stanford, CA |
Other filings by this issuer (7)
More